2Ktete DJ,Begley CG.Recombinant human thrombopoietin:basic bilolgy and evaluation clinical studies[J].Blood,2002,100(10):3457.
3Kosugi S, Kurata Y, Tomiyama Y, et al. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br J Haematol,1996, 93:704-706.
4Usuki K, Tahara T, Iki S, et al. Serum thrombopoietin level in various hematological diseases. Stem Cells, 1996, 14:558-565.
5yon dem Borne A, Folman C, van den Oudenrijn S, et al. The potential role of thrombopoietin in idiopathic thrombocytopenic purpura. Blood Rev, 2002, 16:57-59.
6Shinjo K,Takeshita A,Nakamura S,et al.Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia[J].Leukemia,1998,12:295-300.
7Saroj VR,Claire FV,Carlos BR,et al.Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer[J].Ann Intern Med,2000; 132:364-368.
8Wolff SN,Herzig R,Lynch J,et al.Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation:a phase I pharmacoknetic and phamacodynamic study[J].Bone Marrow Transplantat,2001 ;27:261-268.
